AxioMx Overview
- Year Founded
-
2012

- Status
-
Acquired/Merged
- Employees
-
28

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$33.8M
AxioMx General Information
Description
Developer of synthetic recombinant antibody based in Branford, Connecticut. The company develops synthetically generated affinity reagents, which are fragments of monoclonal antibodies that specifically bind to target proteins and are useful in life science research, diagnostic tests and as therapeutics, enabling patients to increase their resistance against diseases.
Contact Information
Website
www.axiomxinc.comCorporate Office
- 688 East Main Street
- Branford, CT 06405
- United States
Corporate Office
- 688 East Main Street
- Branford, CT 06405
- United States
AxioMx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 11-Nov-2015 | $33.8M | Completed | Startup | ||
5. Grant | 13-Oct-2015 | Completed | Startup | |||
4. Early Stage VC (Series A) | 16-Oct-2014 | Completed | Startup | |||
3. Grant | 01-Sep-2014 | Completed | Startup | |||
2. Early Stage VC | 12-Sep-2013 | $3.86M | $3.86M | Completed | Startup | |
1. Grant | 01-Jan-2013 | $1.6M | Completed | Startup |
AxioMx Comparisons
Industry
Financing
Details
AxioMx Competitors (14)
One of AxioMx’s 14 competitors is Creative Diagnostics, a Corporation company based in Shirley, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Creative Diagnostics | Corporation | Shirley, NY | ||||
DJS Antibodies | Formerly VC-backed | Bicester, United Kingdom | ||||
ABclonal Yurogen | Formerly Accelerator/Incubator backed | Worcester, MA | ||||
Absolute Antibody | Private Equity-Backed | Redcar, United Kingdom | ||||
Agrisera | Formerly PE-Backed | Vannas, Sweden |
AxioMx Patents
AxioMx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-9969792-B2 | Methods and compositions for producing a chimeric polypeptide | Active | 12-Jun-2015 | ||
US-11192939-B2 | Methods and compositions for producing a chimeric polypeptide | Active | 12-Jun-2015 | ||
US-20160362476-A1 | Methods and compositions for producing a chimeric polypeptide | Active | 12-Jun-2015 | ||
AU-2016274571-A1 | Methods and compositions for producing a chimeric polypeptide | Active | 12-Jun-2015 | ||
AU-2016274571-B2 | Methods and compositions for producing a chimeric polypeptide | Inactive | 12-Jun-2015 | C07K16/00 |
AxioMx Signals
AxioMx Former Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Connecticut Innovations | Venture Capital | Minority | ||
Elm Street Ventures | Venture Capital | Minority | ||
National Institute of General Medical Sciences | Government | |||
U.S. Department of Health and Human Services | Government | |||
VC23 Investors | Venture Capital | Minority |
AxioMx FAQs
-
When was AxioMx founded?
AxioMx was founded in 2012.
-
Where is AxioMx headquartered?
AxioMx is headquartered in Branford, CT.
-
What is the size of AxioMx?
AxioMx has 28 total employees.
-
What industry is AxioMx in?
AxioMx’s primary industry is Biotechnology.
-
Is AxioMx a private or public company?
AxioMx is a Private company.
-
What is the current valuation of AxioMx?
The current valuation of AxioMx is
. -
What is AxioMx’s current revenue?
The current revenue for AxioMx is
. -
How much funding has AxioMx raised over time?
AxioMx has raised $7.07M.
-
Who are AxioMx’s investors?
Connecticut Innovations, Elm Street Ventures, National Institute of General Medical Sciences, U.S. Department of Health and Human Services, and VC23 Investors are 5 of 6 investors who have invested in AxioMx.
-
Who are AxioMx’s competitors?
Creative Diagnostics, DJS Antibodies, ABclonal Yurogen, Absolute Antibody, and Agrisera are some of the 14 competitors of AxioMx.
-
When was AxioMx acquired?
AxioMx was acquired on 11-Nov-2015.
-
Who acquired AxioMx?
AxioMx was acquired by Abcam.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »